-- Pharmaceutical firm SSY Group (HKG:2005) said it received drug production and registration approvals for three of its products in China, according to a Hong Kong bourse filing Wednesday.
The approval from China's National Medical Products Administration covers a fat-soluble vitamin injection, metformin hydrochloride tablets for type 2 diabetes, and doxazosin mesylate extended release tablets for benign prostatic hyperplasia and hypertension.
WiseTech Global (ASX:WTC) reaffirmed its fiscal 2026 earnings before interest, taxes, depreciation, and amortization (EBITDA) guidance of AU$550 million to AU$585 million on a reported basis, providing confidence that it is on the right trajectory to return to an EBITDA margin of over 50% in fiscal 2028, Jefferies said in a note on Tuesday.The firm also offered clarity around its one-off costs, separating restructuring costs of AU$37.5 million as well as mergers and acquisition expenses of AU$11 million to AU$15 million.Amazon is opening its end-to-end logistics capabilities to external enterprise shippers, which could lead to a second-order impact for WiseTech. Traditional freight forwarders and logistics providers, its core customer base, may lose market share to Amazon, but it could also be a catalyst for them to modernize their information technology systems using CargoWise and E2open from WiseTech.The investment firm retained its buy rating and price target of AU$72 on WiseTech.WiseTech Global's shares shed about 2% in recent Wednesday trade.
The Lottery's (ASX:TLC) updated dividend framework should keep leverage within range, although higher NIC drag on cashflow sees limited improvement in dividend yield, Jefferies said in a note on Tuesday.It secured an agreement with the Victorian state government for a 40-year extension of the public lottery license. The license is extended to June 30, 2068, with the company paying an upfront premium of AU$1.15 billion to the state. The payment will be entirely made in the first half of fiscal year 2027.The analysts expect the firm's focus to be on organic growth opportunities, and it is likely to target additional revenue opportunities, such as portfolio enhancement, going forward.The investment firm retained a hold rating and cut the price target to AU$5.60 per share from AU$6 per share.
Shenzhen Zhongjin Lingnan Nonfemet (SHE:000060) completed the registration and establishment of a new subsidiary, Shaoguan Zhongjin Lingnan Wanhou Nonferrous Mining, according to a Shenzhen bourse filing on Wednesday.The subsidiary has a registered capital of 30 million yuan. It will process minerals, conduct geological exploration and provide engineering management services.The non-ferrous metals miner's shares jumped 6% during midday trade Wednesday.